Want to see HK:1112 full AI Analyst Report?
1112 Stock Chart & Stats
HK$14.19
-HK$0.04(-0.48%)
At close: 4:00 PM EST
HK$14.19
-HK$0.04(-0.48%)
Day’s Range― - ―
52-Week RangeHK$10.10 - HK$16.80
Previous CloseN/A
Volume756.14K
Average Volume (3M)2.14M
Market Cap
HK$9.05B
Enterprise ValueHK$16.63K
Total Cash (Recent Filing)HK$1.73B
Total Debt (Recent Filing)HK$9.06B
Price to Earnings (P/E)42.1
Beta0.88
Next Earnings
Sep 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.77%
Share Statistics
EPS (TTM)0.30
Shares Outstanding645,561,340
10 Day Avg. Volume985,367
30 Day Avg. Volume2,140,320
Financial Highlights & Ratios
PEG Ratio-0.08
Price to Book (P/B)1.26
Price to Sales (P/S)0.53
P/FCF Ratio7.98
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$19.80Price Target Upside39.56% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
EPS Forecast (FY)1.27
Revenue Forecast (FY)HK$16.48B
Bulls Say, Bears Say
Bulls Say
High Gross MarginsSustained gross margins near 60–64% indicate durable product-level economics for H&H's nutrition portfolio. High margins provide structural buffer to absorb marketing and channel costs, support reinvestment in brand and innovation, and underpin long-run profitability if mix and pricing hold.
Consistent Positive Free Cash FlowMaterial and recurring free cash flow provides a durable funding source for working capital, debt servicing and strategic investment. Even after a decline, positive FCF (~HK$0.95B in 2025) demonstrates cash-conversion strength versus many consumer peers over a multi-year horizon.
Multi-channel Branded PlatformA branded portfolio sold through both online and offline channels gives H&H structural distribution resilience. Multi-channel reach supports diversified demand, enables channel mix optimization, and reduces reliance on any single retailer or platform over the medium term.
Bears Say
Elevated LeverageHigh and persistent leverage (D/E ~1.5x) reduces financial flexibility and magnifies earnings shocks. With limited structural equity cushion, interest and principal obligations constrain capital allocation and raise refinancing risk if cash flows weaken or rates rise over the coming months.
Volatile Profitability And Weak ROEEarnings volatility and a sharp fall in ROE reflect margin pressure and inconsistent profit capture. Thin net margin (~1.4% in 2025) limits retained earnings growth, elevates sensitivity to cost or demand swings, and undermines compounding returns over a multi-quarter horizon.
Weak Cash Coverage For DeleveragingAlthough FCF is positive, a 20.6% decline and low operating cash flow relative to debt (coverage ~0.22) imply slow deleveraging capacity. This constrains the pace of balance-sheet repair and leaves the company exposed if cash generation weakens further.
Health and Happiness (H&H) International Holdings News
1112 FAQ
What was Health and Happiness (H&H) International Holdings Limited’s price range in the past 12 months?
Health and Happiness (H&H) International Holdings Limited lowest stock price was HK$10.10 and its highest was HK$16.80 in the past 12 months.
What is Health and Happiness (H&H) International Holdings Limited’s market cap?
Health and Happiness (H&H) International Holdings Limited’s market cap is HK$9.05B.
When is Health and Happiness (H&H) International Holdings Limited’s upcoming earnings report date?
Health and Happiness (H&H) International Holdings Limited’s upcoming earnings report date is Sep 01, 2026 which is in 46 days.
How were Health and Happiness (H&H) International Holdings Limited’s earnings last quarter?
Health and Happiness (H&H) International Holdings Limited released its earnings results on Mar 24, 2026. The company reported HK$0.212 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Health and Happiness (H&H) International Holdings Limited overvalued?
According to Wall Street analysts Health and Happiness (H&H) International Holdings Limited’s price is currently Undervalued.
Does Health and Happiness (H&H) International Holdings Limited pay dividends?
Health and Happiness (H&H) International Holdings Limited pays a Quarterly dividend of HK$0.16 which represents an annual dividend yield of 1.77%. See more information on Health and Happiness (H&H) International Holdings Limited dividends here
What is Health and Happiness (H&H) International Holdings Limited’s EPS estimate?
Health and Happiness (H&H) International Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Health and Happiness (H&H) International Holdings Limited have?
Health and Happiness (H&H) International Holdings Limited has 645,561,340 shares outstanding.
What happened to Health and Happiness (H&H) International Holdings Limited’s price movement after its last earnings report?
Health and Happiness (H&H) International Holdings Limited reported an EPS of HK$0.212 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.782%.
Which hedge fund is a major shareholder of Health and Happiness (H&H) International Holdings Limited?
Currently, no hedge funds are holding shares in HK:1112
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Health and Happiness (H&H) International Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
HK$19.80 (39.56% Upside)
HK$19.80 (39.56% Upside)
Blogger Sentiment
Bullish
HK:1112 Sentiment 100%
Sector Average 62%
Sector Average 62%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
38.69%
12-Months-Change
Fundamentals
Return on Equity
3.27%
Trailing 12-Months
Asset Growth
7.56%
Trailing 12-Months
Company Description
Health and Happiness (H&H) International Holdings Limited
As an investment holding entity, Health and Happiness (H&H) International Holdings Limited specializes in the global production and distribution of nutritional and care products designed for families and infants. Its offerings are categorized into several key segments. The Infant Formulas division crafts nutritional formulas for children up to age seven, alongside specialized milk products for pregnant and breastfeeding women. The Probiotic Supplements division provides various forms of probiotics, including sachets, capsules, and tablets, catering to the needs of babies, children, and expecting mothers. Within its Adult Nutrition and Care Products segment, H&H develops and markets a range of items such as vitamins, general health supplements, skincare solutions, and sports nutrition for grown-ups. Complementing its infant offerings, the Other Pediatric Products segment focuses on manufacturing dried baby foods, additional nutritional supplements, and general baby care items. Furthermore, its Pet Nutrition and Care segment creates pet food, health-enhancing supplements, and bone broth products for animals. Beyond these core product lines, the company's activities extend to research, development, and processing of diverse ingredients like meat, fruit, and vegetable powders, as well as candies. It actively researches, develops, manufactures, and sells specialized nutritional foods, manages the marketing and distribution of organic baby foods, and handles the wholesale, retail, import, and export of infant nutritional and personal care products. H&H also engages in the trading and sale of adult vitamins, health supplements, probiotic skincare, and sports nutrition items, while offering online sales platforms, software and IT solutions, and packaging services. Its extensive product portfolio is marketed under well-known brands such as Biostime, Swisse, Aurelia, Zesty Paws, Solid Gold, Dodie, Good Gout, Aurelia London, and CBII. Established in 1999, the company adopted its current name, Health and Happiness (H&H) International Holdings Limited, in June 2017, having previously operated as Biostime International Holdings Limited. Headquartered in Quarry Bay, Hong Kong, H&H functions as a subsidiary of Biostime Pharmaceuticals (China) Limited.
Health and Happiness (H&H) International Holdings (1112) Earnings & Revenues
1112 Stock 12 Month Forecast
Average Price Target
HK$19.80
▲(39.56% Upside)
Technical Analysis
Want Want China Holdings
―
China Mengniu Dairy Co
―
Vitasoy International Holdings
―
Ausnutria Dairy Corp. Ltd.
―
China Feihe Limited
―







